MSICS Pharma: Funding, Investors & Team (Oct 2026)
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
MSICS Pharma has raised $3.6M across 1 funding round on record, the most recent a Seed of $3.6M announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MSICS Pharma Company Profile and Key Stats
Latest funding round on record: May 2026.
MSICS Pharma Funding Rounds
MSICS Pharma Founders and Leadership Team
Contact details for the MSICS Pharma team: 1 has a LinkedIn profile.
Start 14-day free trial →MSICS Pharma Funding Compared to Other Biotechnology Startups
MSICS Pharma's latest round of $3.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MSICS Pharma in Biotechnology and Tel Aviv
Companies Similar to MSICS Pharma
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and…
MSICS Pharma Funding FAQs
What does MSICS Pharma do?
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
How much funding has MSICS Pharma raised?
MSICS Pharma has raised $3.6M across 1 round on record. The most recent is a Seed of $3.6M announced in May 2026.
When did MSICS Pharma last raise funding?
MSICS Pharma's most recent funding round on record is a Seed of $3.6M, announced in May 2026.
Who founded MSICS Pharma?
FundedIQ lists Roei Zerahia (Founder) at MSICS Pharma.
Where is MSICS Pharma headquartered?
MSICS Pharma is based in Tel Aviv, Tel Aviv, Israel.
How many employees does MSICS Pharma have?
MSICS Pharma is in the 1-10 employee band.
How does MSICS Pharma's funding compare to other Biotechnology startups?
MSICS Pharma's latest round of $3.6M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MSICS Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MSICS Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.